A detailed history of Qube Research & Technologies LTD transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 106,053 shares of MEDP stock, worth $42.7 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
106,053
Previous 33,928 212.58%
Holding current value
$42.7 Million
Previous $10.4 Million 312.16%
% of portfolio
0.07%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$284.87 - $413.31 $20.5 Million - $29.8 Million
72,125 Added 212.58%
106,053 $42.9 Million
Q4 2023

Feb 13, 2024

BUY
$227.52 - $312.68 $2.18 Million - $3 Million
9,594 Added 39.43%
33,928 $10.4 Million
Q3 2023

Nov 13, 2023

BUY
$233.98 - $281.67 $3.39 Million - $4.08 Million
14,494 Added 147.3%
24,334 $5.89 Million
Q2 2023

Aug 14, 2023

SELL
$187.26 - $240.17 $2.08 Million - $2.67 Million
-11,108 Reduced 53.03%
9,840 $2.36 Million
Q1 2023

May 15, 2023

BUY
$174.31 - $239.52 $1.19 Million - $1.63 Million
6,823 Added 48.3%
20,948 $3.94 Million
Q4 2022

Feb 14, 2023

BUY
$153.06 - $226.57 $2.16 Million - $3.2 Million
14,125 New
14,125 $3 Million
Q3 2021

Nov 12, 2021

SELL
$170.18 - $198.21 $546,107 - $636,055
-3,209 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$158.62 - $194.3 $88,034 - $107,836
555 Added 20.91%
3,209 $567,000
Q1 2021

May 14, 2021

BUY
$132.02 - $168.26 $105,483 - $134,439
799 Added 43.07%
2,654 $435,000
Q4 2020

Feb 16, 2021

SELL
$109.38 - $149.19 $1.33 Million - $1.81 Million
-12,153 Reduced 86.76%
1,855 $258,000
Q3 2020

Nov 12, 2020

BUY
$92.95 - $130.61 $743,600 - $1.04 Million
8,000 Added 133.16%
14,008 $1.57 Million
Q2 2020

Aug 14, 2020

BUY
$68.08 - $95.68 $409,024 - $574,845
6,008 New
6,008 $559,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $12.5B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.